Global Polyene Phosphatidylcholine Market Is Expected to Grow At A CAGR of 4.2% from 2020 to 2027

Polyene phosphatidylcholine is an unsaturated version of phosphatidylcholine which is derived from natural sources such as soybeans, eggs, sunflowers, mustard, etc. It is interchangeably mentioned as lecithin which is a different chemical moiety. It has a vital role in the transfer of phosphatidylcholine transfer protein (PCTP) within cell membranes and is the activation of enzymes having significance in the metabolic functions of the liver. Liver diseases are reigning the clinical application segment for the polyene phosphatidylcholine market. According to the latest statistics provided by the National Institute of Health (NIH),…

Read More

Global Hematology Probes Market Is Expected to Grow At A CAGR of 10.1% from 2020 to 2027

Hematology probes are used in molecular diagnostic techniques such as RT-PCR, Fluorescence in situ hybridization (FISH), Amplification Refractory Mutation System (ARMS), etc. for the elucidation of different gene mutation and loci responsible for the occurrence of blood disorders. Blood cancer is reigning the clinical application segment for the hematology probes market. According to the latest research citings provided by the World Health Organization, approximately 300,000 new cases of leukemia are reported annually throughout the globe, which is responsible for 2.8% of all the new cancer cases recorded worldwide. Further clinical…

Read More

Global Audiometric Screening Equipment Market Is Expected to Grow At A CAGR of 6.6% from 2020 to 2027

According to the statistics provided by the World Health Organization (WHO), by 2050 it is estimated that 1 in 10 people will be suffering from hearing disability worldwide. Technological advancement in the audiometric screening equipment will drive the market growth in the near future. Conductive hearing loss is dominating the largest market share in the indication segment for audiometric screening equipment. It occurs when the sound is blocked either in the outer ear canal or the middle ear. The chief causative factors associated with the disease etiology are patients suffering…

Read More

Global Corticosteroid Nasal Sprays Market Is Expected To Grow At A CAGR Of 4.5% From 2020 To 2027

The latest information provided by the American Academy of Allergy Asthma and Immunology (AAAAI), it is estimated that 10-30 percent of the global population is suffering from allergic rhinitis. Rising prevalence of chronic rhinosinusitis and seasonal flu together will drive the corticosteroid nasal sprays market. The major hurdle faced by this market is the intense competition imposed by the antihistaminic nasal sprays for providing symptomatic relief of the upper respiratory tract infections. Budesonide is presently spearheading the drug class segment for corticosteroid nasal sprays market. It is used as first-line…

Read More

Global Gait Rehabilitation System Market Is Expected to Grow At A CAGR of 8.2% from 2020 to 2027

According to the latest research citings provided by the world health organization (WHO), the prevalence rate of stroke in the Caucasian population is 500–600 per 100,000 people worldwide. A multidisciplinary approach is being utilized by physiotherapists in understanding the entire aspects of the physical and psychological requirements of ambulation in daily life multitasking. Gait trainer walkers are reigning the product type segment for the gait rehabilitation system market. The gait trainer walker can be custom made according to the age and ambulatory functions of the concerned individual. Research studies have…

Read More

Global Neurotrophic Keratitis Market is anticipated to expand at a CAGR of 5.1% from 2019 to 2027

The major symptoms associated with neurotrophic keratitis are red & dry eyes, blurred vision, pain, and discomfort in the eye. Approval of promising drugs such as Oxervate and TB4 is going to completely revolutionize the treatment regimen for neurotrophic keratitis during the forecast period. National Organization for Rare Disease has designated neurotrophic keratitis is a rare disease highlighting a prevalence rate of 5 per 10,000 people. The major causative agent is the herpes zoster virus and herpes simplex virus. The clinical manifestation of the disease is the progressive damage of nerve innervations…

Read More

Global Ketotifen Fumarate Market is expected to grow at a CAGR of 2.9% from 2020 to 2027

As per the latest information brought forward by the World Health Organization (WHO) each year approximately 250,000 deaths related to asthma are reported worldwide. Ketotifen fumarate is ketotifen is a selective, non-competitive H1 receptor antagonist and mast cell stabilizer which is frequently used for the treatment of various kinds of allergic reactions. As per the latest statistics brought forward by the Global Asthma Report 2018, asthma causes the death of 1000 people every day and approximately affects 339 million people worldwide. Currently Atopic asthma is dominating the indication segment for…

Read More

Global Orthopedic Electrosurgical Units Market is Expected to Grow at a CAGR of 5.2% from 2020 to 2027

The principle associated with electrosurgery is that the patient is connected with the device by 2 electrodes, and an electric voltage is created between the electrodes by the device. In electrosurgery, the heating is endogenous which is generated by the flow of current in the tissues. The distribution and quantity of released heat are determined by the tissue resistance, voltage, and the geometry of the current path. Monopolar electrosurgical units are reigning the types segment in the orthopedics electrosurgical units market. They exhibit tremendous versatility in performing modalities such as…

Read More

Global Glaucoma Drugs Market is expected to grow at a CAGR of 4.0% from 2020 to 2027

According to the latest statistics provided by the International Agency for the Prevention of Blindness (IAPB) by 2020, approximately 3.2 million people will be reported blind due to glaucoma. Researchers are working on developing novel drug development for the treatment of glaucoma. Prostaglandins are spearheading the drug class segment for the glaucoma drug market. They are currently used as a first-line therapy due to positive patient compliance as only a single dose is required daily, it acts by relaxing muscles of the eyes interior structure in order to promote fluid…

Read More

Global Flecainide Market is expected to grow at a CAGR of 3.2% from 2020 to 2027

Flecainide is classified as a class 1 antiarrhythmic drug which received USFDA approval in 1985 for the treatment of atrial fibrillation and ventricular tachycardia. It causes the inhibition of the sodium and potassium ion channels in the heart causing an increase in the heart threshold for depolarization and correcting arrhythmias. It is available in doses of 50,100 and 150mg tablets for the treatment of different severity of cardiac arrhythmias. Supraventricular tachycardia is presently leading the indication segment for the flecainide market. The chief causative agents for its clinical manifestations are…

Read More